AU2001258106A1 - Lipid carrier compositions for improved drug retention - Google Patents

Lipid carrier compositions for improved drug retention

Info

Publication number
AU2001258106A1
AU2001258106A1 AU2001258106A AU5810601A AU2001258106A1 AU 2001258106 A1 AU2001258106 A1 AU 2001258106A1 AU 2001258106 A AU2001258106 A AU 2001258106A AU 5810601 A AU5810601 A AU 5810601A AU 2001258106 A1 AU2001258106 A1 AU 2001258106A1
Authority
AU
Australia
Prior art keywords
lipid carrier
improved drug
carrier compositions
drug retention
retention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258106A
Inventor
Marcel B. Bally
Nancy Dos Santos
Lawrence D. Mayer
Paul Tardi
Murray Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELATOR TECHNOLOGIES Inc
Original Assignee
CELATOR TECHNOLOGIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CELATOR TECHNOLOGIES Inc filed Critical CELATOR TECHNOLOGIES Inc
Publication of AU2001258106A1 publication Critical patent/AU2001258106A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001258106A 2000-05-11 2001-05-11 Lipid carrier compositions for improved drug retention Abandoned AU2001258106A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20339900P 2000-05-11 2000-05-11
US60203399 2000-05-11
PCT/CA2001/000655 WO2001085131A2 (en) 2000-05-11 2001-05-11 Lipid carrier compositions for improved drug retention

Publications (1)

Publication Number Publication Date
AU2001258106A1 true AU2001258106A1 (en) 2001-11-20

Family

ID=22753830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258106A Abandoned AU2001258106A1 (en) 2000-05-11 2001-05-11 Lipid carrier compositions for improved drug retention

Country Status (2)

Country Link
AU (1) AU2001258106A1 (en)
WO (1) WO2001085131A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE475411T1 (en) 2001-10-03 2010-08-15 Celator Pharmaceuticals Inc LIPOSOME LOADING WITH METAL IONS
US20060193902A1 (en) * 2003-04-02 2006-08-31 Celator Pharmaceuticals, Inc. Pharmaceutical compositions containing active agents having a lactone group and transition metal ions
AU2005291807B2 (en) 2004-10-06 2012-04-19 Bc Cancer Agency Liposomes with improved drug retention for treatment of cancer
US20090285878A1 (en) 2004-11-05 2009-11-19 Tekmira Pharmaceuticals Corporation Compositions and methods for stabilizing liposomal drug formulations
EP2190411A2 (en) * 2007-08-21 2010-06-02 Alza Corporation Liposome compositions for in vivo administration of boronic acid compounds
TWI549679B (en) 2011-11-03 2016-09-21 台灣微脂體股份有限公司 Pharmaceutical compositions of hydrophobic camptothecin derivatives
US10980798B2 (en) 2011-11-03 2021-04-20 Taiwan Liposome Company, Ltd. Pharmaceutical compositions of hydrophobic camptothecin derivatives
EP2903595A1 (en) * 2012-10-04 2015-08-12 University Of The Witwatersrand, Johannesburg Liposomal drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843473A (en) * 1989-10-20 1998-12-01 Sequus Pharmaceuticals, Inc. Method of treatment of infected tissues
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5997899A (en) * 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
NZ511112A (en) * 1998-09-16 2003-11-28 Alza Corp Lipsome-entrapped topoisomerase inhibitors

Also Published As

Publication number Publication date
WO2001085131A3 (en) 2002-04-25
WO2001085131A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU2002340669A1 (en) Lipid carrier compositions with enhanced blood stability
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
EG24225A (en) Solid lipid formulations
AU3556400A (en) Pharmaceutical compositions
AU761544C (en) Medicinal compositions containing anti-Fas antibody
AU6715600A (en) Pharmaceutical formulations
AU2792700A (en) Pharmaceutical composition containing cyclosporin
HUP0201644A3 (en) Liposome compositions for improved drug retention
AU6460400A (en) Pharmaceutical compositions
AU2001273919A1 (en) Pharmaceutical compositions
PL358616A1 (en) Lipid carrier
AU2001258106A1 (en) Lipid carrier compositions for improved drug retention
AU7937500A (en) Pharmaceutical composition containing midazolam
AU4977300A (en) Pharmaceutical formulations
AU8832301A (en) Pharmaceutical composition having modified carrier
AU6460200A (en) Pharmaceutical compositions
AU1385801A (en) Pharmaceutical formulations
HUP0202652A3 (en) Pharmaceutical carrier composition
AU4085201A (en) Pharmaceutical composition
AU4822500A (en) Novel highly lipophilic camptothecin analogs
AU2001245867A1 (en) Creatine containing caramel
AU2002211005A1 (en) Lipid peroxide-lowering compositions